Loading
A phase 1/2 trial in colorectal cancer, run by University of Saskatchewan, not yet recruiting.
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer is a phase 1/2, interventional study registered as NCT06047015 by University of Saskatchewan, with a registry enrolment figure of 12 participants, started 2025-07 and due to reach its primary completion in 2027-12. Interventions recorded: IRE plus checkpoint inhibitor; IRE plus Checkpoint Inhibitor plus CpG-ODN. Conditions listed: Liver Metastasis Colon Cancer. Primary outcome: Complications; Complications; Abscopal effect: percent change in non-treated colorectal liver metastasis.. Colorectal eligibility wording from the registry: "Biopsy-proven colorectal liver metastases with at least one measuring \< 3". No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.